Back to search results

Personalized Supportive Care for Cancer-Related Fatigue

This study is looking at a personalized program to help people with certain types of lymphoma (indolent lymphomas, chronic lymphocytic leukemia, small lymphocytic lymphoma, follicular lymphoma) manage cancer-related fatigue. The program includes individualized exercise plans and dietary advice from an oncology dietitian. The goal of the study is to see how many patients who agree to participate are referred to this program. We don't know the current recruitment status. You can join if you are 18 or older, provide written consent, and can follow the study procedures. There are no specific biomarkers required to participate.

Study design
This is an interventional study with a planned enrollment of 40 participants. All participants will receive the exercise and dietary intervention program.
What's involved
You would engage in two consultations for exercise and nutrition, follow an individualized exercise plan, and receive tailored dietary recommendations. You would also complete weekly exercise journals and dietary adherence assessments.
Compensation
Not stated in the trial record.
Follow-up
Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06860880

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

Recruiting
NAAges 18+InterventionalSupportive care
UNC Lineberger Comprehensive Cancer Center
~40 participants
Updated 2026-07-01 on ClinicalTrials.gov
What's tested:ExerciseDiet

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
The proportion of consented patients who are referred
Measured over Baseline

Conditions

Indolent Lymphomas
Lymphoma
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Follicular Lymphoma
Marginal Zone Lymphoma
Lymphoplasmacytic Lymphoma
Waldenstrom Macroglobulinemia
Cutaneous T Cell Lymphoma

Explore related trials

Chronic Lymphocytic LeukemiaFollicular LymphomaIndolent LymphomaLymphoplasmacytic LymphomaMarginal Zone LymphomaPrimary Cutaneous T-Cell Non-Hodgkin LymphomaSmall Lymphocytic LymphomaWaldenstrom Macroglobulinemia

Where it's being run

1 sites across 1 states
North Carolina1

Study leadership

  • Christopher Jensen, MD MSCR · PRINCIPAL_INVESTIGATOR · UNC Lineberger Comprehensive Cancer Center

Who to contact

Devin McCarthy
[email protected]
(919)-445-4852
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Written informed consent was obtained to participate in the study and HIPAA authorization for the release of personal health information.
Subjects are willing and able to comply with study procedures based on the judgment of the investigator.
Age ≥ 18 years at the time of consent.
Confirmed diagnosis of indolent lymphoma, Waldenström's Macroglobulinemia, or Cutaneous T Cell Lymphoma.
Significant symptoms of fatigue, as defined by PROMIS Fatigue score \>50.

Exclusion

Other co-existing malignancies.
Significant cognitive impairment as defined by Mini-Cog score 0-2 (out of 5) that would prevent understanding of assessments or interventions.
Unstable or serious illness (e.g., unstable cardiac arrhythmia, severe anemia/thrombocytopenia) that would prevent safe participation in an exercise regimen, per the discretion of the treating physician.
Individuals who are not able to consume an oral diet, due to swallowing difficulties or other reasons, as this might interfere with the nutritional intervention

What this trial measures

  • The proportion of consented patients who are referredBaseline

    The proportion of consented patients with chronic lymphocytic leukemia (CLL) or other forms of indolent lymphoma who are referred to cancer rehabilitation and dietician and attend an initial appointment with each.